MedTrace Logo

Countermeasures to Reduce Sensorimotor Impairment and Space Motion Sickness Resulting From Altered Gravity Levels

NCT02136420 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-01-08

Study results available
· View outcomes & findings →

Summary

The investigators will study adaptation of motion perception and manual control in altered gravity, including the effects of a drug (promethazine). The investigators will also study whether promethazine affects motion perceptual thresholds.

Conditions

  • Vestibular

Interventions

DRUG

Promethazine

Subject receives promethazine

BEHAVIORAL

Hyper gravity training

Subject receives hypergravity training before testing

DRUG

Placebo

Placebo

BEHAVIORAL

No hypergravity training

Subjects do not receive normal Earth gravity

Sponsors & Collaborators

Principal Investigators

  • Faisal Karmali, Ph.D. · Massachusetts Eye and Ear Infirmary

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02136420 on ClinicalTrials.gov